Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.

Gambichler, T; Scholl, L; Dickel, H; Ocker, L; Stranzenbach, R

Gambichler, T; Scholl, L; Dickel, H; Ocker, L; Stranzenbach, R.

Gambichler T; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Scholl L; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Dickel H; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Ocker L; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.
Stranzenbach R; Department of Dermatology, Ruhr-University Bochum, Bochum, Germany.

J Eur Acad Dermatol Venereol ; 35(7): e415-e416, 2021 Jul.

Article in English | MEDLINE | ID: covidwho-1194134

Subject(s)

COVID-19 Vaccines/adverse effects; COVID-19; Erythema Multiforme/chemically induced; Vaccination/adverse effects; BNT162 Vaccine; COVID-19/prevention & control; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Erythema Multiforme / Vaccination / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Eur Acad Dermatol Venereol Journal subject: Dermatology / Sexually Transmitted Diseases Year: 2021 Document Type: Article Affiliation country: Jdv.17225

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google